Government Briefs

No Room For Minority Bricks And Mortar Leading figures in biomedical research from academe, industry, and the federal government have told Congress that giving minority institutions a larger share of federal construction funds is vital to the long-term health of the nation. But their recent “Report on Extramural Biomedical Research Facilities Construction” makes clear that their support for enlarging the number of federal grantees holds only in the case of a rising tide that lifts

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Leading figures in biomedical research from academe, industry, and the federal government have told Congress that giving minority institutions a larger share of federal construction funds is vital to the long-term health of the nation. But their recent “Report on Extramural Biomedical Research Facilities Construction” makes clear that their support for enlarging the number of federal grantees holds only in the case of a rising tide that lifts all ships. “Although suppdrt for [broadening the pool] was quite strong,” says the report from the Department of Health and Human Services, which is based on a one-day meeting last spring at the National Academy of Sciences, “participants expressed doubts about how widely held this position would be in the event of a stable or reducing research budget.” The report to the House and Senate appropriations committees explains that ‘broadening the institutional pool is seen as a zero-sum game. While there may ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies